In partnership with
🖱
Google DeepMind just dropped AlphaGenome 2, an AI that predicts how genetic mutations mess with your cells.
Not just tissues specific cell types.
This is the kind of precision that could crack open how diseases actually start.
But wait, there's more:
Anthropic's CEO told investors cancer and Alzheimer's will be "relics of the past" in under a decade
The same company just switched from Nvidia to AMD chips in three days using AI
I’m Alex. Welcome to L8R by Innov8.
Let’s dive deep.
In today’s post:
Google DeepMind's AlphaGenome 2 predicts genetic mutations at the cell level
Anthropic's CEO promises to cure cancer and Alzheimer's in under a decade
Anthropic says AI broke Nvidia's CUDA moat in three days
DeepMind's AlphaGenome 2 Zooms In On Your DNA
Finding the exact cause of a disease just got a massive upgrade.
Google DeepMind dropped AlphaGenome 2 to predict exactly how genetic changes affect specific cells in your body.
Researchers can now spot the tiny DNA glitches that cause sickness instead of just guessing.
The details:
DeepMind trained this new model on over 100 million individual cell profiles across 68 human and mouse tissues.
The AI looks at specific cell types instead of whole organs, making it much more accurate than the first version.
In tests on immune cells, AlphaGenome 2 found 30% of disease-causing variants, nearly double the old model's score.
Researchers can plug in their own cell data to get instant predictions on how genes will act.
It is available right now for non-commercial research through an API.
Why it matters:
Old DNA models looked at entire organs and missed the small details.
It was like trying to find a broken pixel by looking at a whole screen.
AlphaGenome 2 zooms right in on the exact cell type to see what goes wrong.
This gives drug makers a perfect target to build better medicines that actually work.
💡 L8R's Take:
DeepMind is slowly mapping the entire human body with AI.
Forget chatbots, this is the kind of AI that will actually save lives.
AlphaGenome 2 is a massive leap toward curing diseases we thought were impossible to beat.
From Our Partner
Introducing Fair Game from Vanity Fair
Join Mark Guiducci for a series of in-depth and far-reaching conversations with the most interesting characters from the worlds of Hollywood, Politics, Style, Silicon Valley, and beyond. It's all Fair Game.
Anthropic's $1.4 Trillion Pitch: Curing Cancer in a Decade
Anthropic CEO Dario Amodei is making a massive promise to investors.
He says AI will wipe out cancer, Alzheimer's, and heart disease in less than ten years.
It is a bold claim designed to hype up their upcoming $1.4 trillion IPO.
The details:
Amodei made the claim in a 42-minute roadshow video for potential investors.
He believes AI will speed up medical research, packing 100 years of progress into just five to ten years.
Anthropic wants to sell shares between $70 and $78 to hit a $1.4 trillion valuation under the ticker symbol ANT.
Medical experts like Eric Topol and Gary Marcus are calling his bluff.
Experts point out that normal drug trials take 10 to 12 years just to get approved by regulators.
Why it matters:
Anthropic is selling a dream to get Wall Street excited.
They want to be seen as a company that creates miracles, not just another software maker.
But there is a huge gap between AI hype and real-world medicine.
Biology is messy, and AI cannot skip the long, strict process of human clinical trials.
💡 L8R's Take:
Amodei is writing checks his AI cannot cash. '
Curing cancer sounds great on an IPO video, but it is a dangerous way to pump up a stock price.
Investors should buy Anthropic for its software, not for a magical medical revolution that ignores the rules of biology.
From Our Partners
Get Paid for Data You Already Own
Your business has years of emails, documents, CRM records and call logs. AI researchers need exactly that kind of real-world data, and Mode will pay for it.
You sell a de-identified copy. Your original records and systems remain yours.
No broker fees. Mode buys directly.
You approve what data gets shared.
You never share your passwords.
Sensitive information is removed before delivery.
It takes just a few hours of your team’s time.
Depending on data volume and a full review, companies with several years of records could see 100K–5M.
See if your company qualifies and get a quote.
Anthropic Just Broke Nvidia's Biggest Trap
Nvidia's biggest advantage is a software trap called CUDA that makes it incredibly hard to switch to other chips. Anthropic just smashed right through it.
They used their own AI to move Claude to AMD chips in just three days instead of a whole year.
The details:
Anthropic used an internal AI model called Mythos to write nearly 100% of the code needed to switch chips.
Normally, moving an AI model to new hardware takes dozens of engineers six to twelve months of hard work.
The AI finished the job for AMD Instinct MI355X GPUs in roughly 72 hours with almost zero human help.
Anthropic revealed this massive win during its November 2026 IPO roadshow.
This move is part of Anthropic's plan to treat chips from Nvidia, AMD, Google, and AWS as one giant pool of power.
Anthropic and AMD already signed a huge deal in July 2026 for a massive two-gigawatt data center.
Why it matters:
AI companies usually get stuck buying expensive Nvidia chips because changing software is too hard.
If AI can rewrite the code automatically, that wall disappears. Companies can just buy whatever chip is cheapest and fastest.
This makes Nvidia's massive monopoly very weak.
💡 L8R's Take:
I love seeing a clever software trick break a massive hardware monopoly.
Nvidia has bullied the market for years because everyone was stuck in their ecosystem.
If AI can code its way out of the CUDA trap, the whole chip market is about to turn into a brutal price war.
🚀 Quick L8R Summary
AlphaGenome 2: Google DeepMind dropped an AI that predicts how genetic mutations mess with specific cell types trained on 100M+ cell profiles to help researchers hunt down disease drivers.
Anthropic's Bold Claim: Anthropic's CEO told investors that cancer, Alzheimer's, heart disease, and mental illness will be "relics of the past" in under a decade a massive promise during their IPO pitch.
AI vs CUDA Moat: Anthropic used its own AI to port Claude to AMD chips in just three days, proving that AI itself is breaking Nvidia's CUDA stranglehold faster than anyone expected.
📩 Innathe L8R engane undarunnu 👇?
We read every reply - just reply to this email and let us know how we can improve !
Appo adutha L8R il kanaam bie…👋